Maryland Capital Management Bristol Myers Squibb CO Transaction History

Maryland Capital Management

$1.2 Billion
Q3 2022

A detailed history of Maryland Capital Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Maryland Capital Management holds 6,495 shares of BMY stock, worth $382,360. This represents 0.04% of its overall portfolio holdings.

Number of Shares

6,495

Previous 6,995 7.15%

Holding current value

$382,360

Previous $539,000 14.29%

% of portfolio

0.04%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $65 - $38,420	-500 Reduced 7.15%	6,495 $462,000
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $17,706 - $21,231	-288 Reduced 3.95%	6,995 $511,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $28,316 - $33,010	-528 Reduced 6.76%	7,283 $454,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $27,928 - $32,714	472 Added 6.43%	7,811 $462,000
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $77,201 - $84,072	-1,247 Reduced 14.52%	7,339 $490,000
Q1 2021 May 11, 2021	SELL	$59.34 - $66.74 $272,370 - $306,336	-4,590 Reduced 34.84%	8,586 $542,000
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $750 - $850	13 Added 0.1%	13,176 $817,000
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $143,804 - $159,354	-2,504 Reduced 15.98%	13,163 $794,000
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $14,636 - $17,112	-267 Reduced 1.68%	15,667 $921,000
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $64,496 - $93,727	-1,390 Reduced 8.02%	15,934 $888,000
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $23,620 - $30,811	480 Added 2.85%	17,324 $1.11 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $37,851 - $44,878	-885 Reduced 4.99%	16,844 $854,000
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $67,376 - $74,503	-1,510 Reduced 7.85%	17,729 $804,000
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $13,310 - $15,871	-295 Reduced 1.51%	19,239 $918,000
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $11,214 - $14,542	230 Added 1.19%	19,534 $1.02 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $52,982 - $59,760	-960 Reduced 4.74%	19,304 $1.2 Million
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $65,891 - $82,125	-1,304 Reduced 6.05%	20,264 $1.12 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $205,285 - $236,325	3,426 Added 18.88%	21,568 $1.36 Million
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $5,094 - $5,554	85 Added 0.47%	18,142 $1.11 Million
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $27,062 - $31,232	-490 Reduced 2.64%	18,057 $1.15 Million
Q2 2017 Aug 14, 2017	BUY	N/A	18,547	18,547 $1.03 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Maryland Capital Management with notifications on news.

Account

Maryland Capital Management Bristol Myers Squibb CO Transaction History